Product logins

Find logins to all Clarivate products below.


Biosurgical Agents | Market Insights | Asia Pacific | 2025

The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical hemostats and high awareness among physicians about the clinical benefits of biosurgical agents in various procedures.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for biosurgical agents in the US from 2019 through 2033.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
ENT Devices – Market Insights – Japan
The Japanese ENT device market is projected to grow at a modest pace over the forecast period, supported by a slight increase in ENT procedure volumes. This growth will be primarily driven by a…
Report
Video and High-Tech Hardware Devices – Market Insights – United States
The US video and high-tech hardware device market will experience modest expansion through 2035. This growth is primarily driven by the increasing adoption of articulated surgical robotic systems…
Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market will experience steady moderate growth through 2035, supported by the gradual expansion of MIS volumes and selective adoption of highervalue…